What if we could make CAR-T cells inside the body?

CAR-T therapies have operational scaling challenges (see above). Maybe viral vectors can circumvent those challenges by modifying your T cells while they’re still inside a patient. “Scientists are devising ways to edit the genomes of immune cells without having to extract them from those being treated.” ~ learn more